Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (ages 18-80) on PN with silicone-based central venous catheters~Exclusion Criteria:~* Weight ≤ 50 kg~* Allergy/hypersensitivity/intolerance to ethanol or heparin~* Pregnancy or breastfeeding~* Patient taking metronidazole, disulfiram, or isoniazid~* History of alcohol abuse~* History of heparin-induced thrombocytopenia (HIT) or have an active hypocoagulable state

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Ethanol lock (Type: ACTIVE_COMPARATOR): 70% ethanol
- Heparin lock (Type: ACTIVE_COMPARATOR): Heparinized saline (100 U/mL)

Based on this trial design, predict the completion outcome and termination type (if applicable).